Is there any test for prostate cancer that doesn’t depend on a blood test for PSA?

Posted by  | Prevention/Screening

“There are an increasing collection of tests that sample other aspects of prostate cancer in urine, blood or tissue, including acquired gene defects in the disease and acquired changes that cancers display that normal cells don’t,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “I would(...)

What are the signs of spiritual distress for cancer patients?

Posted by  | treatment

No matter how you respond to your diagnosis, it’s not unusual for cancer patients to feel the impact of spiritual pain and distress, says Rhonda Cooper, an oncology chaplain at the Johns Hopkins Kimmel Cancer Center in Baltimore.  Signs of spiritual distress for cancer patients may include: Guilt or regrets about things you have done(...)

How can I figure out if prostate cancer screening will help me personally?

Posted by  | Prevention/Screening

“The best approach is to have a significant conversation with your physician about the risks and benefits of screening. It's shared decision making,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “People have different attitudes about what they’d like to do with their health. If someone(...)

Top Maryland scientists discuss research on tracking and treating cancer

Posted by  | Research

At the annual Research Matters conference yesterday, top scientists from the Johns Hopkins Kimmel Cancer Center and University of Maryland Greenebaum Cancer Center discussed research using advanced imaging methods to develop better ways pinpoint and track cancer cells — down to the microscopic level — and precisely target each cell with anti-cancer drugs. Experts also delivered presentations(...)

What you need to know about prostate cancer screening guidelines

Posted by  | Prevention/Screening

Prostate-specific antigen (PSA)-based screening for prostate cancer has received mixed reviews from different organizations, says William G. Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer Center. Today, the United States Preventive Services Task Force has posted draft recommendations for prostate screening that encourage men ages 55 - 69 to make individual decisions about(...)

Improving the ‘Care’ in Cancer Care

Posted by  | Uncategorized

*This blog post was written by the Kimmel Cancer Center's development specialist, Allison Rich. Anyone who has ever heard the words “you have cancer” knows that no part of their life remains unaffected by the reality of this diagnosis. Yet even though we know this to be true, the traditional approach to cancer medicine has(...)

Johns Hopkins Student Wins Top Prize For Research on Lethal Brain Tumors in Children

Johns Hopkins Student Wins Top Prize For Research on Lethal Brain Tumors in Children

Posted by  | Childhood Cancer, Research

Johns Hopkins undergraduate student Sabrina Wang won first place in a competition among 125 students for her research on a lethal type of pediatric brain tumor called atypical teratoid/rhabdoid tumors (AT/RT), the most common brain tumor type in infants. The award was presented at the AACR 2017 annual meeting in Washington, D.C., on April 2.(...)

Making Real and Measureable Progress with Immunotherapy

Posted by  | treatment

--This blog post celebrates the one-year anniversary of the launch of the Bloomberg~Kimmel Institute for Cancer Immunotherapy. When we launched the Bloomberg~Kimmel Institute for Cancer Immunotherapy last March, we committed to accelerate the progress of immunotherapies in a real and measurable way, taking advantage of its ability to produce unprecedented and durable cancer regressions. We(...)